Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$46.49

1.13 (2.49%)

14:24
06/03/19
06/03
14:24
06/03/19
14:24

Bristol-Myers updates results from studies evaluating Opdivo

Bristol-Myers Squibb announced updated results from studies evaluating Opdivo alone or in combination, in patients with advanced or metastatic melanoma. These analyses will be featured on Monday, June 3 from 1:15-4:15 PM CDT at the American Society of Clinical Oncology 2019 Annual Meeting in Chicago. A five-year analysis of the Phase 1 CA209-004 study, the longest follow-up for the Opdivo plus Yervoy combination in patients with previously treated or untreated advanced melanoma to date, showed that with a median follow-up of 43.1 months in all patients, at four years or longer, overall survival rates were stable at 57%.The three-year OS rate following discontinuation of therapy was 56%. The study also showed long-term survival outcomes with Opdivo plus Yervoy, regardless of BRAF or lactate dehydrogenase status, with four-year OS rates of 62% versus 49% for patients with normal and elevated LDH, respectively, and four-year OS rates of 54% and 61% for patients with wild-type and mutant BRAF tumors, respectively. The overall safety of the combination was consistent with previously reported studies of these medicines in patients with advanced melanoma.

BMY Bristol-Myers
$46.49

1.13 (2.49%)

05/20/19
05/20/19
DOWNGRADE

Hold
Bristol-Myers downgraded to Hold from Buy at Argus
As previously reported, Argus analyst David Toung downgraded Bristol-Myers (BMY) to Hold from Buy, saying he has "serious concerns" about the company's growth prospects after its announced acquisition of Celgene (CELG). The analyst contends that Celgene's pipeline is not sufficient to offset the expected decline in revenues from its Revlimid, which will lose exclusivity in 2026. Toung adds that Bristol-Myers' "patent cliff" is also notable with loss of exclusivity expected for Opdivo in 2028, Eliquis in 2026, and Orencia in 2021. While the stock trades at 10.5-times forward earnings multiple - a discount to the 12-times peer group average - the analyst believes the valuation is appropriate.
05/28/19
GSCO
05/28/19
INITIATION
Target $54
GSCO
Buy
Bristol-Myers initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Terence Flynn started Bristol-Myers Squibb with a Buy rating and $54 price target. Bristol-Myers is trading at a "significant discount to the group," Flynn tells investors in a research note. The analyst says his call is based on valuation, and he sees potential for multiple expansion whether or not the Celgene (CELG) acquisition closes.
05/28/19
GSCO
05/28/19
DOWNGRADE
Target $60
GSCO
Sell
Goldman sees negative sales growth for Gilead, downgrades shares to Sell
Goldman Sachs analyst Terence Flynn downgraded Gilead Sciences (GILD) to Sell from Neutral and lowered his price target for the shares to $60 from $70. The analyst expects Gilead's sales growth to decelerate saying the Truvada/Atripla loss of exclusivities in Sept ember 2020 represents a $3B headwind. Further, Biktarvy can only protect about half of the company's $16B HIV franchise from generic competition, Flynn tells investors in a research note. As a result, the analyst models annual revenue growth for Gilead through 2022 as negative 5%, which he notes is among the lowest in his coverage universe. Meanwhile, the stock trades at a slight premium to other stocks such as Bristol-Myers (BMY) and AbbVie (ABBV), says Flynn.
05/30/19
GUGG
05/30/19
NO CHANGE
GUGG
Buy
Array BioPharma could be seen as target after 'de-risking' data, says Guggenheim
Guggenheim analyst Michael Schmidt said Array Biopharma (ARRY) may be perceived by investors as a theoretical acquisition target following the disclosure of Phase 3 interim results of Braftovi/Mektovi in BRAF+ colorectal cancer, which he views as positive and a "de-risking event." 67% of announced acquisitions in oncology with a comparable market cap to Array had what he would consider major pipeline de-risking events in the 6 months prior to their deal announcements, Schmidt tells investors. Merck (MRK) and Pfizer (PFE) "seem to have most bandwidth for a deal," said Schmidt, who added that those two along with Bristol-Myers (BMY), AstraZeneca (AZN) and Roche (RHHBY) scored highest as possible large cap theoretical acquirers of Array in his analysis. Schmidt raised his price target on Array Biopharma shares to $38 from $37, though his analysis suggests a potential $40-$50 acquisition price if the company were to be bought.

TODAY'S FREE FLY STORIES

PM

Philip Morris

$79.12

0.8 (1.02%)

, HON

Honeywell

$163.86

0.2 (0.12%)

20:25
10/16/19
10/16
20:25
10/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$79.12

0.8 (1.02%)

HON

Honeywell

$163.86

0.2 (0.12%)

UNP

Union Pacific

$163.31

0.11 (0.07%)

MS

Morgan Stanley

$42.82

0.28 (0.66%)

BBT

BB&T

$53.00

0.25 (0.47%)

STI

SunTrust

$68.28

0.23 (0.34%)

PPG

PPG

$118.89

0.665 (0.56%)

MTB

M&T Bank

$159.14

0.27 (0.17%)

KEY

KeyCorp

$17.70

-0.08 (-0.45%)

GPC

Genuine Parts

$97.72

-0.22 (-0.22%)

DOV

Dover

$95.71

-0.24 (-0.25%)

TXT

Textron

$50.52

-0.15 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Nov

  • 08

    Nov

  • 10

    Nov

  • 11

    Nov

  • 12

    Nov

GLD

SPDR Gold Shares

$140.39

0.81 (0.58%)

20:11
10/16/19
10/16
20:11
10/16/19
20:11
Hot Stocks
SPDR Gold Shares holdings fall to 918.19MT from 919.66MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.60

-0.15 (-4.00%)

19:20
10/16/19
10/16
19:20
10/16/19
19:20
Hot Stocks
Aurora Cannabis to roll out vapes, concentrates, edibles in Canada in December »

On the one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TEVA

Teva

$6.94

-0.02 (-0.29%)

19:20
10/16/19
10/16
19:20
10/16/19
19:20
Upgrade
Teva rating change at Gabelli »

Teva upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CAAP

Corporacion America Airport

$4.39

-0.09 (-2.01%)

19:14
10/16/19
10/16
19:14
10/16/19
19:14
Hot Stocks
Corporacion America Airport reports September passenger traffic up 1.2% »

Corporacion America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.65

0.38 (1.05%)

19:10
10/16/19
10/16
19:10
10/16/19
19:10
Periodicals
Tentative GM-UAW deal does not include reopening of Lordstown plant, NYP says »

A tentative agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LLNW

Limelight Networks

$3.10

-0.08 (-2.52%)

, NFLX

Netflix

$286.83

2.59 (0.91%)

18:55
10/16/19
10/16
18:55
10/16/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

LLNW

Limelight Networks

$3.10

-0.08 (-2.52%)

NFLX

Netflix

$286.83

2.59 (0.91%)

TCBI

Texas Capital

$54.33

-0.15 (-0.28%)

CSX

CSX

$68.99

-0.18 (-0.26%)

AA

Alcoa

$19.17

-0.28 (-1.44%)

CCI

Crown Castle

$134.76

0.11 (0.08%)

RGLS

Regulus

$0.72

0.0501 (7.54%)

IBM

IBM

$142.04

-0.94 (-0.66%)

URI

United Rentals

$121.73

1.02 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

18:37
10/16/19
10/16
18:37
10/16/19
18:37
Hot Stocks
Netflix says shares viewing data with producers each week »

Says shares viewing data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

BRBR

BellRing Brands

$0.00

(0.00%)

18:34
10/16/19
10/16
18:34
10/16/19
18:34
Syndicate
BellRing Brands 34.29M share IPO priced at $14.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GSBC

Great Southern Bancorp

$57.28

-0.03 (-0.05%)

18:32
10/16/19
10/16
18:32
10/16/19
18:32
Earnings
Great Southern Bancorp reports Q3 preliminary EPS $1.38, consensus $1.23 »

Reports Q3 NII $45.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CRM

Salesforce

$146.96

-5.89 (-3.85%)

, FB

Facebook

$189.62

0.81 (0.43%)

18:26
10/16/19
10/16
18:26
10/16/19
18:26
Hot Stocks
Salesforce CEO: Steve Jobs had a huge impact on my life »

In an interview on…

CRM

Salesforce

$146.96

-5.89 (-3.85%)

FB

Facebook

$189.62

0.81 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 16

    Dec

NFLX

Netflix

$286.83

2.59 (0.91%)

18:19
10/16/19
10/16
18:19
10/16/19
18:19
Hot Stocks
Netflix to test mobile only plans in other markets »

Says will test mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

, LZAGY

Lonza

$0.00

(0.00%)

18:18
10/16/19
10/16
18:18
10/16/19
18:18
Hot Stocks
Mesoblast, Lonza enter into manufacture agreement of remestemcel-L in U.S. »

Mesoblast (MESO) and…

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

LZAGY

Lonza

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$286.83

2.59 (0.91%)

18:12
10/16/19
10/16
18:12
10/16/19
18:12
Hot Stocks
Neflix says price increase responsible for U.S. shortfall »

Says price increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:06
10/16/19
10/16
18:06
10/16/19
18:06
Hot Stocks
Steel Dynamics CEO says steel pricing environment 'challenging' »

"Our third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

18:06
10/16/19
10/16
18:06
10/16/19
18:06
Hot Stocks
Netflix says price increases 'hugely' revenue positive »

Says Q3 was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

DLPN

Dolphin Entertainment

$0.79

(0.00%)

18:05
10/16/19
10/16
18:05
10/16/19
18:05
Syndicate
Dolphin Entertainment offers to sell common stock, no amount given »

Maxim Group LLC is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:03
10/16/19
10/16
18:03
10/16/19
18:03
Hot Stocks
Steel Dynamics says 'constructive' on 2020 North American steel market dynamics »

"Based on domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:01
10/16/19
10/16
18:01
10/16/19
18:01
Earnings
Steel Dynamics reports Q3 EPS 69c, consensus 70c »

Reports Q3 revenue $2.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ISTR

Investar Holding

$23.98

0.08 (0.33%)

18:01
10/16/19
10/16
18:01
10/16/19
18:01
Hot Stocks
Investar Holding gains regulatory, holder approvals for Bank of York acquisition »

Investar Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSX

CSX

$68.99

-0.18 (-0.26%)

17:57
10/16/19
10/16
17:57
10/16/19
17:57
Hot Stocks
CSX reverses in after-hours, trading up over 4% »

Shares of CSX are now up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

EGO

Eldorado Gold

$7.40

0.175 (2.42%)

17:50
10/16/19
10/16
17:50
10/16/19
17:50
Hot Stocks
Eldorado Gold reports Q3 preliminary gold production of 101,596 oz. »

Eldorado Gold reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BHP

BHP Group

$48.17

-0.51 (-1.05%)

17:38
10/16/19
10/16
17:38
10/16/19
17:38
Hot Stocks
BHP Group backs FY20 iron ore output view of 242-253 MT »

Backs FY20 petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

PEGI

Pattern Energy

$26.14

-0.26 (-0.98%)

17:37
10/16/19
10/16
17:37
10/16/19
17:37
Downgrade
Pattern Energy rating change at Goldman Sachs »

Pattern Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

BHP

BHP Group

$48.17

-0.51 (-1.05%)

17:35
10/16/19
10/16
17:35
10/16/19
17:35
Hot Stocks
BHP Group reports Q1 iron ore output 61MT, down 1% from last year »

Reports Q1 petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.